Abstract
Recurrent pregnancy loss (RPL), defined as two or more consecutive miscarriages, is attributable to multiple causes. In about 50% of such couples, no documented cause of pregnancy loss can be found. The feto-placental unit evades rejection by the maternal immune system by poorly understood mechanisms. Each level in the establishment of normal pregnancy has been implicated as a possible site of immune-mediated reproductive failure. Both autoimmune and alloimmune mechanisms have been proposed. Since the mechanisms allowing a mother to tolerate her semi-allogeneic conceptus are not well defined, it is difficult to assess the role of abnormal immunologic factors in reproductive failure. The immunological causes of RPL is usually a diagnosis of exclusion. In this chapter a brief overview of available scientific evidence is provided regarding involvement of immune aberrations in pathogenesis of recurrent pregnancy loss.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Robertson SA. Immune regulation of conception and embryo implantation-all about quality control? J Reprod Immunol. 2010;85:51.
Stoller M, Traupe T, Khattab AA, et al. Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function. Heart. 2013;99:548.
Mor G, Abrahams VM. The immunology of pregnancy. In: Creasy RK, Resnik R, Iams JD, et al., editors. Creasy and Resnik’s maternal-fetal medicine: principles and practice. 7th ed. Philadelphia: Elsevier; 2014. p. 80.
Nagamatsu T, Schust DJ. The contribution of macrophages to normal and pathological pregnancies. Am J Reprod Immunol. 2010;63:460.
Zhang J, Chen Z, Smith GN, Croy BA. Natural killer cell-triggered vascular transformation: maternal care before birth? Cell Mol Immunol. 2011;8:1.
Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta. 2010;31(Suppl):S87.
Management of high-risk pregnancy. In: Queenan JT, Spong CY, Lockwood CJ, editors. Queenan’s high-risk obstetrics. 6th ed. Malden: Blackwell Publishing; 2011.
Mjösberg J, Berg G, Jenmalm MC, Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod. 2010;82:698.
Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. 2012;490:102.
Kwiatek M, Gęca T, Krzyżanowski A, Malec A, Kwaśniewska A. Peripheral dendritic cells and CD4+CD25+Foxp3+ regulatory T cells in the first trimester of normal pregnancy and in women with recurrent miscarriage. PLoS One. 2015;10(5):e0124747.
Weaver CT, Harrington LE, Mangan PR, et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Eur J Onstet Gynecol Reprod Biol. 2012;161:177–81.
Liu YS, Wu L, Tong XH, et al. Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol. 2011;65:503–11.
Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63:601.
Daher S, Mattar R, Gueuvoghlanian-Silva BY, et al. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol. 2012;67:341–7.
Szekeres-Bartho J, Halasz M, Palkovics T. Progesterone in pregnancy; receptor-ligand interaction and signaling pathways. J Reprod Immunol. 2009;83:60.
Morales PJ, Pace JL, Platt JS, et al. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology. 2007;122:179.
Varla-Leftherioti M. The significance of women’s NK cell receptors’ repertoire in the maintenance of pregnancy. Chem Immunol Allergy. 2005;89:84–95.
Menier C, Riteau B, Dausset J, et al. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol. 2000;61:1118–25.
Varla-Leftherioti M. Role of a KIR/HLA-C allorecognition system in pregnancy. J Reprod Immunol. 2004;62:19–27.
Meuleman T, Lashley LELO, Dekkers OM, van Lith JMM, Claas FHJ, Bloemenkamp KWH. HLA associations and HLA sharing in recurrent miscarriage: a systematic review and meta-analysis. Hum Immunol. 2015;76:362–73.
Holder BS, Tower CL, Forbes K, et al. Immune cell activation by trophoblast-derived microvesicles is mediated by syncytin 1. Immunology. 2012;136:184.
Lee KL, Na BJ, Kim JY, Hur SE, Lee M, Gilman-Sachs A, Kwak-Kim J. Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Am J Reprod Immunol. 2013;70:398–411.
Lee SK, Kim JY, Hur SE, Kim CJ, Na BJ, Lee M, Gilman-Sachs A, Kwak-Kim J. An imbalance in interleukin-17-producing T and Foxp3+ regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod. 2011;26(11):2964–71.
Kwak-Kim JY, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod. 2003;18(4):767–73.
Perricone C, De Carolis C, Perricone R. Pregnancy and autoimmunity: a common problem. Best Pract Res Clin Rheumatol. 2012;26:47–60.
Hanafusa N, Noiri E, Yamashita T, et al. Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages. Ther Apher Dial. 2006;10:498.
Christiansen OB. Reproductive immunology. Mol Immunol. 2013;55:8–15.
Varla-Leftherioti M, Keramitsopoulou T, Parapanissiou E, et al. HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop. Tissue Antigens. 2010;75:668–72.
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Degree of TNF-a/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol. 2011;65:610–8.
Beaman KD, Ntrivalas E, Mallers TM, Jaiswal MK, Kwak-Kim J, Gilman-Sachs A. Immune etiology of recurrent pregnancy loss and its diagnosis. Am J Reprod Immunol. 2012;67:319–25. https://doi.org/10.1111/j.1600-0897.2012.01118.x.
Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006;(19):CD000112.
Kim DJ, Lee SK, Kim JY, Na BJ, Hur SE, Lee M, et al. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss. Am J Reprod Immunol. 2014;71(5):441–50.
Ata B, Tan SL, Shehata F, Holzer H, Buckett W. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril. 2011;95:1080–5.
Matthiesen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol. 2012;67:334.
Tang AW, Alfirevic Z, Turner MA, et al. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod. 2013;28:1743–52.
Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;(10):CD000112.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gupta, M. (2018). Immunology and Pregnancy Loss. In: Mehta, S., Gupta, B. (eds) Recurrent Pregnancy Loss. Springer, Singapore. https://doi.org/10.1007/978-981-10-7338-0_4
Download citation
DOI: https://doi.org/10.1007/978-981-10-7338-0_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7337-3
Online ISBN: 978-981-10-7338-0
eBook Packages: MedicineMedicine (R0)